News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Phase III FIRST trial results of REVLIMID® Plus Dexamethasone in newly diagnosed multiple myeloma patients published
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.08]
Celgene Corporation has announced that data from FIRST (MM-020/IFM 07-01) - an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in...
New cancer drug to begin trials in multiple myeloma patients
Source: Cancer / Oncology News From Medical News Today [2014.10.14]
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Metastasis of multiple myeloma prevented by novel compound in mice
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.28]
In an advance against the problem of cancer metastasis, Dana-Farber Cancer Institute scientists have shown that a specially developed compound can impede multiple myeloma from spreading to the bones...
Source: MedicineNet thalidomide Specialty [2013.09.17]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/17/2013 12:00:00 AM
Kyprolis Approved for Multiple Myeloma
Source: MedicineNet thalidomide Specialty [2012.07.23]
Title: Kyprolis Approved for Multiple Myeloma
Category: Health News
Created: 7/20/2012 4:05:00 PM
Last Editorial Review: 7/23/2012 12:00:00 AM